Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

© 2003 by Marcel Dekker, Inc. Voltage-gated sodium (Na+) channels (VGSCs) are complex, transmembrane proteins that have a role in governing electrical activity in excitable tissues. The Na+ channel is activated in response to depolarization of the cell membrane that causes a voltage-dependent conformational change in the channel from a resting, closed conformation to an active conformation, the result of which increases the membrane permeability to Na+ ions (1-3). VGSCs comprise a multisubunit complex consisting of a large (230-to 270-kDa), highly glycosylated a-subunit and one or two smaller accessory β-subunits (β1 and β2)' Most attention has been directed toward the a-subunit, and recent molecular studies have extended the a-subunit gene family to ten separate members that have been characterized in terms of their electrophysiological properties and tissue distribution profile (Figs. I and 2) (418). Based on the sensitivity to a toxin derived from puffer fish, tetrodotoxin (TTX), Na+ currents can be subdivided as either being TTX-sensitive (TTXs) or TTX-resistant (TTXr) (19-24). The four brain-type Na+ channels (brain I, II, ill, and VI) which are predominantly found in the central nervous system (CNS) are inhibited by low nanomolar concentrations of TTX (5,7,11,13). PN-I, which is found in neuroendocrine tissues and in sensory nerves, is also TTXsensitive (12,16), as is the skeletal muscle channel a-subunit (17). By contrast, there are three channels that are inhibited by only micromolar concentrations of TTX, the major cardiac channel hl/SKM2 (10) and two channels, SNS and SNS2 which are expressed only in sensory neurones (4,14,15,18).

Type

Chapter

Book title

Pain: Current Understanding, Emerging Therapies, and Novel Approaches to Drug Discovery

Publication Date

01/01/2003

Pages

607 - 618